Ovarian cancer: a heterogeneous disease
M Kossaï, A Leary, JY Scoazec, C Genestie - Pathobiology, 2018 - karger.com
Ovarian cancer encompasses a collection of neoplasms with distinct clinicopathological and
molecular features and prognosis. Despite there being a variety of ovarian cancer subtypes …
molecular features and prognosis. Despite there being a variety of ovarian cancer subtypes …
[HTML][HTML] Pathobiology of ovarian carcinomas
M Devouassoux-Shisheboran, C Genestie - Chinese journal of cancer, 2015 - Springer
Ovarian tumors comprise a heterogeneous group of lesions, displaying distinct tumor
pathology and oncogenic potentiel. These tumors are subdivided into three main categories …
pathology and oncogenic potentiel. These tumors are subdivided into three main categories …
Oncologic results of fertility sparing surgery of cervical cancer: an updated systematic review
…, S Espenel, P Pautier, A Leary, C Genestie… - Gynecologic …, 2022 - Elsevier
Background Several techniques can be proposed as fertility sparing surgery in young
patients treated for cervical cancer but uncertaincies remain concerning their outcomes …
patients treated for cervical cancer but uncertaincies remain concerning their outcomes …
Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma
P Pautier, C Genestie, A Rey, P Morice, B Roche… - Cancer, 2000 - Wiley Online Library
Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a
grading score validated for soft tissue sarcoma - Pautier - 2000 - Cancer - Wiley Online Library …
grading score validated for soft tissue sarcoma - Pautier - 2000 - Cancer - Wiley Online Library …
[HTML][HTML] Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
…, LR Mileshkin, A Fyles, A Leary, C Genestie… - British journal of …, 2023 - nature.com
Background Risk-assessment of endometrial cancer (EC) is based on clinicopathological
factors and molecular subgroup. It is unclear whether adding hormone receptor expression …
factors and molecular subgroup. It is unclear whether adding hormone receptor expression …
[HTML][HTML] Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)
SJL Mesnage, A Auguste, C Genestie, A Dunant… - Annals of oncology, 2017 - Elsevier
Background Lymphocytic infiltration at diagnosis is prognostic in EOC, however, the impact
of NACT on tumour infiltrating lymphocytes (TILs) or PD-L1 expression remains poorly …
of NACT on tumour infiltrating lymphocytes (TILs) or PD-L1 expression remains poorly …
[HTML][HTML] p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial
…, N Singh, ME Powell, RJ Edmondson, C Genestie… - Modern …, 2022 - nature.com
Standard molecular classification of endometrial cancers (EC) is now endorsed by the WHO
and identifies p53-abnormal (p53abn) EC as the subgroup with the poorest prognosis and …
and identifies p53-abnormal (p53abn) EC as the subgroup with the poorest prognosis and …
Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the …
C Genestie, B Zafrani, B Asselain, A Fourquet… - Anticancer …, 1998 - europepmc.org
The most commonly used system in Europe for breast carcinoma was developed by Scarff,
Bloom and Richardson (SBR). It was recently modified by Elston and Ellis and significant …
Bloom and Richardson (SBR). It was recently modified by Elston and Ellis and significant …
Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers
…, M Guillaud‐Bataille, G Le Teuff, C Genestie… - Clinical …, 2017 - Wiley Online Library
We addressed uncertainties regarding hereditary leiomyomatosis and renal cell carcinoma
(HLRCC) by exploring all French cases, representing the largest series to date. Fumarate …
(HLRCC) by exploring all French cases, representing the largest series to date. Fumarate …
[PDF][PDF] Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients
Background: The aim of this series was to study the clinical impact of initial surgical
management, particularly of uterine mor-cellation, on patients treated for uterine sarcoma …
management, particularly of uterine mor-cellation, on patients treated for uterine sarcoma …